埃罗替尼
吉非替尼
医学
肺癌
盐酸厄洛替尼
肿瘤科
内科学
癌症
表皮生长因子受体
作者
Vince D. Cataldo,Don L. Gibbons,Román Pérez-Soler,Alfonso Quintás-Cardama
标识
DOI:10.1056/nejmct0807960
摘要
A 64-year-old woman receives the diagnosis of metastatic non-small-cell lung cancer (NSCLC), which has progressed during treatment with carboplatin, paclitaxel, and bevacizumab. Erlotinib therapy is recommended.
科研通智能强力驱动
Strongly Powered by AbleSci AI